NuVasive commenced commercial launch of the NuVasive Tube System (NTS) and Excavation Micro, a new minimally invasive surgery (MIS) system for both TLIF and decompression. These additions expand the offerings within the NuVasive P360 portfolio.
Engineered to enhance the surgical workflow, NTS and Excavation Micro create a complete procedural offering with the company’s Advanced Materials Science and expandable interbody implants, biologics, Reline fixation system and enabling technologies within the Pulse platform.
Ryan Donahoe, Chief Technology Officer at NuVasive, said, “Our P360 portfolio is now complemented by the launch of our NTS and Excavation Micro solutions that are specifically designed to increase workflow speed while delivering improved safety and reproducibility.”
NuVasive commenced commercial launch of the NuVasive Tube System (NTS) and Excavation Micro, a new minimally invasive surgery (MIS) system for both TLIF and decompression. These additions expand the offerings within the NuVasive P360 portfolio.
Engineered to enhance the surgical workflow, NTS and Excavation Micro create a complete procedural...
NuVasive commenced commercial launch of the NuVasive Tube System (NTS) and Excavation Micro, a new minimally invasive surgery (MIS) system for both TLIF and decompression. These additions expand the offerings within the NuVasive P360 portfolio.
Engineered to enhance the surgical workflow, NTS and Excavation Micro create a complete procedural offering with the company’s Advanced Materials Science and expandable interbody implants, biologics, Reline fixation system and enabling technologies within the Pulse platform.
Ryan Donahoe, Chief Technology Officer at NuVasive, said, “Our P360 portfolio is now complemented by the launch of our NTS and Excavation Micro solutions that are specifically designed to increase workflow speed while delivering improved safety and reproducibility.”
Copy to clipboard 
